Clinical and biological implications of Hippo pathway dysregulation in sarcomas
Authors
Anastasios Kyriazoglou
Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece
Roubini Zakopoulou
Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece
Flora Zagouri
Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece
Aristotelis Bamias
Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece
Meletios Athanasios Dimopoulos
Department of Clinical Therapeutics, General Hospital Alexandra, Athens, Greece
Language: English
Page range: 11 - 16
Submitted on: Sep 24, 2018
Accepted on: Feb 28, 2019
Published on: Jul 12, 2019
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2019 Anastasios Kyriazoglou, Roubini Zakopoulou, Flora Zagouri, Aristotelis Bamias, Meletios Athanasios Dimopoulos, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.